Specific derivatization of the vesicle monoamine transporter with novel carrier-free radioiodinated reserpine and tetrabenazine photoaffinity labels

Analytical Biochemistry

Volumn 367, Issue 1, 2007, Pages 68-78

  Sievert, Michael K ^a   Hajipour, Abdol R ^a,b   Ruoho, Arnold E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b ISFAHAN UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

Photoaffinity labels; Reserpine; Tetrabenazine; Vesicle monoamine transporter; VMAT2

Indexed keywords

AMINES; ELECTROPHORESIS; GRANULATION; NEUROPHYSIOLOGY; RADIOGRAPHY; SULFUR COMPOUNDS;

PHOTOAFFINITY; RESERPINE; TETRABENAZINE; VESICLE MONOAMINE TRANSPORTER; VMAT2;

SODIUM DODECYL SULFATE;

18 O [3 (3' IODO 4' AZIDOPHENYL)PROPIONYL]METHYLRESERPATE; 18 O [N (3' IODO 4' AZIDOPHENETHYL)GLYCYL]METHYLRESERPATE; 2 N [(3' IODO 4' AZIDOPHENYL)PROPIONYL]TETRABENAZINE; AZIDE; CARRIER PROTEIN; DOPAMINE; IODINE 125; RESERPINE; TETRABENAZINE; TRITIUM; UNCLASSIFIED DRUG; VESICLE MONOAMINE TRANSPORTER 2;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; CHROMAFFIN GRANULE; CONTROLLED STUDY; IC 50; MOLECULAR WEIGHT; NONHUMAN; PHOTOAFFINITY LABELING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RADIOIODINATION;

EID: 34250683814     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.04.046     Document Type: Article

References (47)

1. Usera P.C., Vincent S., and Robertson D. Human phenotypes and animal knockout models of genetic autonomic disorders. J. Biomed. Sci. 11 (2004) 4-10
2. Itokawa K., Sora I., Schindler C.W., Itokawa M., Takahashi N., and Uhl G.R. Heterozygous VMAT2 knockout mice display prolonged QT intervals: possible contributions to sudden death. Brain Res. Mol. Brain Res 71 (1999) 354-357
3. Choi H.J., Lee S.Y., Cho Y., and Hwang O. Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease. Neurochem. Int. 46 (2005) 329-335
4. Kariya S., Takahashi N., Hirano M., and Ueno S. Increased vulnerability to L-DOPA toxicity in dopaminergic neurons From VMAT2 heterozygote knockout mice. J. Mol. Neurosci. 27 (2005) 277-279
5. Lee W.Y., Lee E.A., Jeon M.Y., Kang H.Y., and Park Y.G. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration. Exp. Neurol. 197 (2006) 215-224
6. Bly M. Mutation in the vesicular monoamine gene, SLC18A1, associated with schizophrenia. Schizophr Res 78 (2005) 337-338
7. Zucker M., Aviv A., Shelef A., Weizman A., and Rehavi M. Elevated platelet vesicular monoamine transporter density in untreated patients diagnosed with major depression. Psychiatry Res 112 (2002) 251-256
8. Frize E.D. Mental depression in hypertensive pantients treated for long periods with high doses of reserpine. N. Engl. J. Med. 251 (1954) 1006-1008
9. Zubieta J.K., Huguelet P., Ohl L.E., Koeppe R.A., Kilbourn M.R., Carr J.M., Giordani B.J., and Frey K.A. High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates. Am. J. Psychiatry 157 (2000) 1619-1628
10. Schwab S.G., Franke P.E., Hoefgen B., Guttenthaler V., Lichtermann D., Trixler M., Knapp M., Maier W., and Wildenauer D.B. Association of DNA polymorphisms in the synaptic vesicular amine transporter gene (SLC18A2) with alcohol and nicotine dependence. Neuropsychopharmacology 30 (2005) 2263-2268
11. +-ATPase of chromaffin granules. Kinetics, regulation, and stoichiometry. J. Biol. Chem. 257 (1982) 10701-10707
12. Floor E., and Leeman S.E. Identification and characterization of the major proteins of mammalian brain synaptic vesicles. J. Neurochem. 50 (1988) 1597-1604
13. +-ATPase in neurosecretory granules from bovine posterior pituitary. J. Biol. Chem. 265 (1990) 9165-9169
14. Bashford C.L., Casey R.P., Radda G.K., and Ritchie G.A. Energy-coupling in adrenal chromaffin granules. Neuroscience 1 (1976) 399-412
15. Pletscher A. Transport of monoamines in membranes of adrenal chromaffin granules: physiological and pharmacological aspects. Bull. Schweiz. Akad. Med. Wissenschaften 32 (1976) 181-190
16. Howell M., Shirvan A., Stern-Bach Y., Steiner-Mordoch S., Strasser J.E., Dean G.E., and Schuldiner S. Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules. FEBS Lett 338 (1994) 16-22
17. Krejci E., Gasnier B., Botton D., Isambert M.F., Sagne C., Gagnon J., Massoulie J., and Henry J.P. Expression and regulation of the bovine vesicular monoamine transporter gene. FEBS Lett 335 (1993) 27-32
18. Johnson R.G., Pfister D., Carty S.E., and Scarpa A. Biological amine transport in chromaffin ghosts. Coupling to the transmembrane proton and potential gradients. J. Biol. Chem. 254 (1979) 10963-10972
19. Knoth J., Zallakian M., and Njus D. Mechanisms of proton-linked monoamine transport in chromaffin granule ghosts. Fed. Proc. 41 (1982) 2742-2745
20. Feany M.B., Lee S., Edwards R.H., and Buckley K.M. The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell 70 (1992) 861-867
21. Calamia J., and Manoil C. lac permease of Escherichia coli: topology and sequence elements promoting membrane insertion. Proc. Nat. Acad. Sci. 87 (1990) 4937-4941
22. Kaback H.R. The lactose permease of Escherichia coli: a paradigm for membrane transport proteins. Biochim. Biophys. Acta 1101 (1992) 210-213
23. Thiriot D.S., Sievert M.K., and Ruoho A.E. Identification of Human Vesicle Monoamine Transporter (VMAT2) Lumenal Cysteines That Form an Intramolecular Disulfide Bond. Biochemistry 41 (2002) 6346-6353
24. Darchen F., Scherman D., and Henry J.P. Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporter. Biochemistry 28 (1989) 1692-1697
25. Scherman D., and Henry J.P. Reserpine binding to bovine chromaffin granule membranes. Characterization and comparison with dihydrotetrabenazine binding. Mol. Pharmacol. 25 (1984) 113-122
26. Stern-Bach Y., Greenberg-Ofrath N., Flechner I., and Schuldiner S. Identification and purification of a functional amine transporter from bovine chromaffin granules. J. Biol. Chem. 265 (1990) 3961-3966
27. 3H]dihydrotetrabenazine. Proc. Nat. Acad. Sci. USA 80 (1983) 584-588
28. Darchen F., Scherman D., Laduron P.M., and Henry J.P. Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles. Mol. Pharmacol. 33 (1988) 672-677
29. Peter D., Jimenez J., Liu Y., Kim J., and Edwards R.H. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J. Biol. Chem. 269 (1994) 7231-7237
30. 125I]2-N-[(3′-iodo-4′-azidophenyl)propionyl]tetrabenazine binding sites for the synaptic vesicle monoamine transporter. J. Biol. Chem. 272 (1997) 26049-26055
31. Dorfman L., Furlenmeier C.F., Huebner C.F., Lucas R., MacPhillamy H.B., Mueller J.M., Schittler E., Schwyzer R., and St. Andre A.F. Die Konstitution des Reserpins. Helvitica Chim. Acta 37 (1954) 59-75
32. 125I]iodoazidocymarin. J. Biol. Chem. 259 (1984) 10533-10538
33. Adams R., and Ulich L.H. The use of oxalyl chloride and bromide for producing acid chlorides, acid bromides or acid anhydrides. III. J. Am. Chem. Soc. 42 (1920) 599-611
34. Resek J.F., and Ruoho A.E. Photoaffinity labeling the beta-adrenergic receptor with an iodoazido derivative of norepinephrine. J. Biol. Chem. 263 (1988) 14410-14416
35. Smith A.D., and Winkler H. Purification and properties of an acidic protein from chromaffin granules of bovine adrenal medulla. Biochem. J. 103 (1967) 483-492
36. Giraudat J., Roisin M.P., and Henry J.P. Solubilization and reconstitution of the adenosine 5′-triphosphate dependent proton translocase of bovine chromaffin granule membrane. Biochemistry 19 (1980) 4499-4505
37. Knoth J., Isaacs J.M., and Njus D. Amine transport in chromaffin granule ghosts. pH dependence implies cationic form is translocated. J. Biol. Chem. 256 (1981) 6541-6543
38. Parti R., Ozkan E.D., Harnadek G.J., and Njus D. Inhibition of norepinephrine transport and reserpine binding by reserpine derivatives. J. Neurochem. 48 (1987) 949-953
39. Sievert M.K., Resek J.F., Wu Z., Rong Y., and Ruoho A.E. UV crosslinking of adrenergic receptors and ligands. Detection by SDS- PAGE. Methods Mol. Biol. 126 (2000) 315-327
40. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227 (1970) 680-685
41. Isambert M.F., and Henry J.P. Photoaffinity labeling of the tetrabenazine binding sites of bovine chromaffin granule membranes. Biochemistry 24 (1985) 3660-3667
42. 125I]iodoketanserin. Biochemistry 28 (1989) 2265-2270
43. 3H]dihydrotetrabenazine-binding protein from bovine adrenal medulla. Mol. Pharmacol. 40 (1991) 889-894
44. Gabizon R., Yetinson T., and Schuldiner S. Photoinactivation and identification of the biogenic amine transporter in chromaffin granules from bovine adrenal medulla. J. Biol. Chem. 257 (1982) 15145-15150
45. Near J.A., and Mahler H.R. Reserpine labels the catecholamine transporter in synaptic vesicles from bovine caudate nucleus. FEBS Lett. 158 (1983) 31-35
46. Sievert M.K., Thiriot D.S., Edwards R.H., and Ruoho A.E. High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells. Biochem. J. 330 Pt 2 (1998) 959-966
47. Hansra N., Arya S., and Quick M.W. Intracellular domains of a rat brain GABA transporter that govern transport. J. Neurosci. 24 (2004) 4082-4087